re: "trial where I might be given some unknown control lens"
I should clarify that I simply don't know at the moment what the alternate lens will be, I had the impression they didn't know yet. I imagine they must tell that to the patient upfront, and it seems like there are decent odds it might be the Tecnis multifocal since it is from the same company and available in the US.
Unfortunately the fact that a clinical trial is being done doesn't mean the lens will be approved anytime soon even if it is safe given the red tape and politics that goes into FDA approvals.
re: "Has Canada approved this yet? "
Not as far as I can tell, It seems like some countries follow the US lead, others the EU. I don't think its in Mexico either, where I know they do have the Light Adjustable Lens you'd mentioned in a prior post. I know they are working on multifocal variations of the LAL technique, but as far as I know those are still in the trial stage. I'm an early adopter, but not quite that early. I'd prefer to avoid early stage clinical trials done before any approvals have been granted anywhere.
Even if I don't participate in a trial, I do like the idea of considering a doctor who has participated in early clinical trials for other lenses. I figure the lens companies only pick doctors whose surgical skills they approve of and that they are more likely to have the resources to be a better judge of that than a patient will be. I may be wrong, but it seems like they logically would want the lens results to be based on the best possible surgical outcomes rather than a lens looking bad because the surgeons testing it didn't do a good job.
re: ". I hate how you hear news stories such as below and then you never hear any follow up. "
Yup, though often stories like that one involve early research which may not turn out to lead to anything viable, or it may take longer than expected (like the better accommodating lenses which have been on the horizon the last couple of years).
re: how the Symfony works, it is unfortunate there is limited information about it, but I can't wait too long for more. I don't know if you'd seen the other page on this site where I posted some clips from articles for more info:
http://www.medhelp.org/posts/Eye-Care/Are-my-eyes-getting-worse-because-of-Cataracts/show/2368182
I admit I would prefer to see more analysis of how it works, for instance what it means for how much light is available for each different focal range the way they have analyzed trifocals to show say 20% for intermediate or whatever (usually varying by pupil size&light conditions).
It seems like the description must mean that rather than splitting the light up into distinct focal points X, Y, and Z, that the light is distributed over a more continuous range of focal points from X through Z. Even with a standard monofocal or multifocals the visual system has some "depth of focus" which leads to light coming in at a range of focuses around those concentrated distinct focal points, so that you can see better at distances in between X,Y, and Z.
It would seem logically that the Symfony's approach would seem to give less light at each discrete focal point within that continues range (rather than as in a multifocal more of it concentrated at discrete X,Y, and Z points), so I'm assuming the visual system must use light from within a short interval of nearby focal points, e.g. from the range of focuses between P1 and P2, rather than merely only using the light at precisely P1 or P2. Obviously an accommodating lens that accommodated well would be a better option, but despite some patients having luck with say the Synchrony, the current accommodating lenses don't seem a good enough bet to me.
re: "price in Europe for the lens is expensive"
Actually it appears that I can get the lens (for 1 eye), including travel cheaper than the cheapest cataract surgery with a monofocal here in the US. (even including laser cataract surgery if I decide to go for that). In some other European countries even with travel its comparable to the cost of surgery with a premium lens in the US (at least if you have a high deductible). It is a different tradeoff I know for those with a low deductible just covering the lens cost. However they might wish to factor in the higher odds of needing to pay for correction the rest of their lives if they don't get a premium lens, or the higher risk of needing to explant a US-approved multifocal due to concerns over visual artifacts (which are lower in the newer lenses available elsewhere).
As a US surgeon noted of course, even though this is a very safe surgery, you do wish to be sure you use a good surgeon with low complication rates, and who is likely to hit the refraction target well enough for a premium lens to live up to its potential. Those who aren't willing to do research and take some risk should stick to the US approved lenses.